Catalent Appoints New Vice President and General Manager for European Softgel Business

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has appointed Robert Beland to the newly created role of Vice President & General Manger of Softgel Technologies in Europe.

Mr Beland’s main focus will be on leading initiatives that accelerate overall growth within the European region, working closely with other members of the Softgel Leadership Team to refine and execute strategy, strengthen business development and commercial activities, while extending Catalent’s best in class development and manufacturing capabilities. He will be based at Catalent’s Cham, Switzerland office.

An executive leader, with more than 25 years’ experience in the services industry, both in the pharma and the vitamins, minerals, and supplements (VMS) space, Mr. Beland’s professional career includes 2 years at Catalent’s St Petersburg, Florida facility as Vice President and General Manager for Nutritionals. In his extensive career he has led European and North American businesses. Most recently, Mr Beland was Executive Vice President and Chief Operating Officer for Ricerca Biosciences.

“Robert’s appointment will help to further strengthen our leadership position in the European softgel market,” commented Dr Aris Gennadios, Catalent’s President of Softgel Technologies. “He will particularly focus on driving commercialisation of our recently launched new technologies across the Rx, consumer health and skin care segments, and coordinating our R&D and supply capabilities at our European sites in France, Germany and Italy.”

Mr Beland holds a bachelor’s degree in Chemistry from Université de Montréal, Montréal, QC, Canada and a degree in health sciences from Collège Jean-de Brébeuf, Outremont, QC, Canada.